Trends in sepsis-related neonatal mortality in the United States, 1985-1998

Pediatric Infectious Disease Journal

Volumn 23, Issue 7, 2004, Pages 599-603

  Lukacs, Susan L ^a   Schoendorf, Kenneth C ^a   Schuchat, Anne ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Group B Streptococcus; Neonatal mortality; Prophylaxis; Sepsis; United States data

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ESCHERICHIA COLI; GESTATIONAL AGE; HEALTH STATISTICS; HUMAN; LINEAR REGRESSION ANALYSIS; NEWBORN MORTALITY; PREMATURITY; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

FEMALE; HUMANS; INFANT, NEWBORN; MALE; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

EID: 3142764507     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000131633.74921.90     Document Type: Article

References (24)

1. Stoll BJ, Holman RC, Schuchat A. Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics. 1998;102:e18.
2. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Active Bacterial Core Surveillance (ABCs) of the Emerging Infections Program Network, Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110:690-695.
3. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics. 2001;108:1094-1098.
4. Centers for Disease Control and Prevention. Prevention of perinatal Group B Streptococcal disease: a public health perspective. MMWR Recommendations Rep. 1996;45(RR-7):1-24.
5. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314:1665-1669.
6. American Academy of Pediatrics. Guidelines fro prevention of Group B streptococcal infection by chemoprophylaxis. Pediatrics. 1992;90:775-778.
7. Committee on Infectious Diseases/Committee on Fetus and Newborn, American Academy of Pediatrics. Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. Pediatrics. 1997;99: 489-486.
8. Committee on Obstetric Practice, American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. Washington, DC: American College of Obstetricians and Gynecologists; 1996.
9. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000; 342(1):15-20.
10. Main EK, Slagle T. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols. Am J Obstet Gynecol. 2000;182:1344-1354.
11. Cordero L, Sananes M, Ayers LW. Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program. Infect Control Hosp Epidemiol. 1999;20:242-246.
12. Isaacs D, Royle JA, Australasian Study Group for Neonatal Infections. Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Pediatr Infect Dis J. 1999;18:524-528.
13. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347:240-247.
14. National Center for Health Statistics Linked Birth/Infant Death Data Set: 1985-1991 Cohort Data, 1995-1998 Period Data. Hyattsville, MD: National Center for Health Statistics, 2000.
15. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. National Vital Statistics Reports, vol. 49 no. 2. Hyattsville, MD: National Center for Health Statistics; 2001.
16. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996;87:163-168.
17. Parker JD, Schoendorf KC. Implications of cleaning gestational age data. Paediatr Perinat Epidemiol. 2002;16:181-187.
18. Kleinman JC. Methodologic issues in the analysis of vital statistics. In: Kiely M, ed. Reproductive and Perinatal Epidemiology. Boca Raton, FL: CRC Press; 1991.
19. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recommendations Rep. 2002;51(RR-11):1-22.
20. Joseph TA, Pyati SP, Jacobs N. Neonatal early-onset Escherichia coli disease: the effect of intrapartum ampicillin. Arch Pediatr Adolesc Med. 1998;152:35-40.
21. Towers CV, Briggs GG. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am J Obstet Gynecol. 2002;187:495-500.
22. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartum use of ampicillin. Am J Obstet Gynecol. 1998; 179:879-883.
23. Terrone DA, Rinehart BK, Einstein MH, Britt LB, Martin JN, Perry KG. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol. 1999;180:1345-1348.
24. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285-291.